I-Clindamycin HCL 21462-39-5 I-Antibiotic
Inkokhelo:T/T, L/C
Umsuka Womkhiqizo:China
Imbobo yokuthutha:Beijing/Shanghai/Hangzhou
Amandla okukhiqiza:800kg/ngenyanga
I-oda(MOQ):25kg
Isikhathi esiholayo:3 Izinsuku Zokusebenza
Isimo sesitoreji:Igcinwe endaweni epholile neyomile, ivalwe futhi igweme ukukhanya.
Impahla yephakheji:isigubhu
Usayizi wephakheji:25kg/isigubhu
Ulwazi lokuphepha:Akuzona izimpahla eziyingozi
Isingeniso
I-Clindamycin iyi-semi-synthetic antibiotic ene-spectrum ebanzi ye-antibacterial kanye nomsebenzi onamandla wokulwa namagciwane.Inomsebenzi osobala we-antibacterial ngokumelene namagciwane e-Gram-positive, futhi ingabulala ngempumelelo i-Staphylococcus, i-anaerobic bacteria, i-pneumococcus ne-streptococcus.
Inemiphumela esebenzayo kuma-parasites e-pathogenic afana ne-Pneumocystis, i-Toxoplasma gondii ne-Plasmodium falciparum, futhi ukusabela okubi kuncane.
Ukucaciswa (USP43)
| Into | Ukucaciswa |
| Ukubukeka | Imhlophe noma icishe ibe mhlophe, i-crystalline powder Ayinaphunga noma inephunga elifana nele-mercaptan. |
| Ukuhlonza | A) IR: Ukuvumelana B) Isikhathi sokugcinwa kwesilinganiso esiphakeme esikhulu sesixazululo sesampula sihambisana naleso sesixazululo Esijwayelekile njengoba sitholwe ku-Assay. |
| I-Crystallinity | Ihlangabezana nezidingo |
| Ph | 3.0-5.5 |
| Amanzi | 3.0%-6.0% |
| Izinto Ezihlobene | |
| I-Clindamycin B | ≤2.0% |
| 7-epiclindamycin | ≤4.0% |
| Noma iyiphi enye inhlanganisela yomuntu ngamunye | ≤1.0% |
| Ingqikithi yazo zonke inhlanganisela ehlobene kuhlanganise ne-Lincomycin | ≤6.0% |
| Izincibilikisi ezisele ze-acetone | ≤5000ppm |
| Isivivinyo | ≥830μg/mg |
